Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alpha-Lipoic Acid for Cisplatin-Induced Nephrotoxicity
NCT07564479Phase 2Recruiting
- Sponsor
- Minia University
- Start
- Mar 2026
- Primary completion
- Mar 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of alpha-lipoic acid in cisplatin-induced nephrotoxicity (CIN), sponsored by Minia University. Started Mar 2026; status: recruiting.
02
Drugs
alpha-lipoic acid
03
Conditions
cisplatin-induced nephrotoxicity (CIN)
Beyond the preview
Go deeper on NCT07564479.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07564479.